Literature DB >> 18505901

Human ovarian carcinomas detected by specific odor.

György Horvath1, Gunvor Af Klinteberg Järverud, Sven Järverud, István Horváth.   

Abstract

The high mortality rate associated with ovarian carcinoma is mainly owing to late diagnosis. It is thus essential to develop inexpensive and simple methods for early diagnosis. Papers on canine scent detection of malignancies such as melanoma and bladder, lung, and breast cancer have recently been published in peer-reviewed journals, indicating a new diagnostic tool for malignancies. However, in these studies the dogs may have responded to odors associated with cancer, such as inflammation or metabolic products, rather than specifically to cancer itself. Therefore, it is important to ascertain whether or not human cancers are characterized by specific odors. We hypothesized that if ovarian carcinoma emits a specific odor, dogs may be trained to detect it. Using our training method, we taught a dog to distinguish different histopathological types and grades of ovarian carcinomas, including borderline tumors, from healthy control samples. Double-blind tests showed 100% sensitivity and 97.5% specificity. Moreover, the odor of ovarian carcinomas seems to differ from those of other gynecological malignances such cervical, endometrial, and vulvar carcinomas. Our study strongly suggests that the most common ovarian carcinomas are characterized by a single specific odor.

Entities:  

Mesh:

Year:  2008        PMID: 18505901     DOI: 10.1177/1534735408319058

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  28 in total

Review 1.  Advances in electronic-nose technologies developed for biomedical applications.

Authors:  Alphus D Wilson; Manuela Baietto
Journal:  Sensors (Basel)       Date:  2011-01-19       Impact factor: 3.576

Review 2.  Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds.

Authors:  Daniel K Chan; Cadman L Leggett; Kenneth K Wang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

3.  Characteristic odour in the blood reveals ovarian carcinoma.

Authors:  György Horvath; Håkan Andersson; Gunnar Paulsson
Journal:  BMC Cancer       Date:  2010-11-24       Impact factor: 4.430

4.  Ethnic/racial and genetic influences on cerumen odorant profiles.

Authors:  Katharine A Prokop-Prigge; Corrine J Mansfield; M Rockwell Parker; Erica Thaler; Elizabeth A Grice; Charles J Wysocki; George Preti
Journal:  J Chem Ecol       Date:  2014-12-13       Impact factor: 2.626

Review 5.  Exhaled breath analysis for lung cancer.

Authors:  Annette G Dent; Tom G Sutedja; Paul V Zimmerman
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

6.  Handler beliefs affect scent detection dog outcomes.

Authors:  Lisa Lit; Julie B Schweitzer; Anita M Oberbauer
Journal:  Anim Cogn       Date:  2011-01-12       Impact factor: 3.084

7.  Colorectal cancer screening with odour material by canine scent detection.

Authors:  Hideto Sonoda; Shunji Kohnoe; Tetsuro Yamazato; Yuji Satoh; Gouki Morizono; Kentaro Shikata; Makoto Morita; Akihiro Watanabe; Masaru Morita; Yoshihiro Kakeji; Fumio Inoue; Yoshihiko Maehara
Journal:  Gut       Date:  2011-01-31       Impact factor: 23.059

8.  Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines.

Authors:  Bogusław Buszewski; Tomasz Ligor; Tadeusz Jezierski; Anna Wenda-Piesik; Marta Walczak; Joanna Rudnicka
Journal:  Anal Bioanal Chem       Date:  2012-06-03       Impact factor: 4.142

Review 9.  Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.

Authors:  Kamila Schmidt; Ian Podmore
Journal:  J Biomark       Date:  2015-03-30

10.  Pigeons (Columba livia) as Trainable Observers of Pathology and Radiology Breast Cancer Images.

Authors:  Richard M Levenson; Elizabeth A Krupinski; Victor M Navarro; Edward A Wasserman
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.